I’m just waiting for a yes or no for EAU. If w
Post# of 157795
(Total Views: 606)
Posted On: 08/17/2020 6:05:40 PM
I’m just waiting for a yes or no for EAU.
If we don’t get EAU, then all is lost IMO. Doesn’t take a genius to figure out what to do here. If we don’t hear back by Wednesday then I’ll start to worry what’s going on behind closed doors. Whether that’s with cytodyn or the FDA.
So yes I’m saying we will hear back from the FDA in the next few days.
If we don’t get EAU I expect the announcement over the weekend about the FDAs response. If that happens we have greater problems on our hands with corruption within our government greater than I expected already.
The last thing we need is another trial. Covid will be over by the time this plays out and thousands will have died.
If we don’t get EAU, then all is lost IMO. Doesn’t take a genius to figure out what to do here. If we don’t hear back by Wednesday then I’ll start to worry what’s going on behind closed doors. Whether that’s with cytodyn or the FDA.
So yes I’m saying we will hear back from the FDA in the next few days.
If we don’t get EAU I expect the announcement over the weekend about the FDAs response. If that happens we have greater problems on our hands with corruption within our government greater than I expected already.
The last thing we need is another trial. Covid will be over by the time this plays out and thousands will have died.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36